Skip to main navigation Skip to search Skip to main content

Tuning macrophage phenotype to mitigate skeletal muscle fibrosis

  • David M. Stepien
  • , Charles Hwang
  • , Simone Marini
  • , Chase A. Pagani
  • , Michael Sorkin
  • , Noelle D. Visser
  • , Amanda K. Huber
  • , Nicole J. Edwards
  • , Shawn J. Loder
  • , Kaetlin Vasquez
  • , Carlos A. Aguilar
  • , Ravi Kumar
  • , Shamik Mascharak
  • , Michael T. Longaker
  • , Jun Li
  • , Benjamin Levi*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Abstract

Myeloid cells are critical to the development of fibrosis following muscle injury; however, the mechanism of their role in fibrosis formation remains unclear. In this study, we demonstrate that myeloid cell-derived TGF-b1 signaling is increased in a profibrotic ischemia reperfusion and cardiotoxin muscle injury model. We found that myeloid-specific deletion of Tgfb1 abrogates the fibrotic response in this injury model and reduces fibro/adipogenic progenitor cell proliferation while simultaneously enhancing muscle regeneration, which is abrogated by adaptive transfer of normal macrophages. Similarly, a murine TGFBRII-Fc ligand trap administered after injury significantly reduced muscle fibrosis and improved muscle regeneration. This study ultimately demonstrates that infiltrating myeloid cell TGF-b1 is responsible for the development of traumatic muscle fibrosis, and its blockade offers a promising therapeutic target for preventing muscle fibrosis after ischemic injury.

Original languageEnglish
Pages (from-to)2203-2215
Number of pages13
JournalJournal of Immunology
Volume204
Issue number8
DOIs
StatePublished - 15 Apr 2020

Fingerprint

Dive into the research topics of 'Tuning macrophage phenotype to mitigate skeletal muscle fibrosis'. Together they form a unique fingerprint.

Cite this